COVID-19 R0: Magic number or conundrum?
Identifieur interne : 000883 ( Pmc/Corpus ); précédent : 000882; suivant : 000884COVID-19 R0: Magic number or conundrum?
Auteurs : Giulio Viceconte ; Nicola PetrosilloSource :
- Infectious Disease Reports [ 2036-7430 ] ; 2020.
Url:
DOI: 10.4081/idr.2020.8516
PubMed: 32201554
PubMed Central: 7073717
Links to Exploration step
PMC:7073717Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 R0: Magic number or conundrum?</title><author><name sortKey="Viceconte, Giulio" sort="Viceconte, Giulio" uniqKey="Viceconte G" first="Giulio" last="Viceconte">Giulio Viceconte</name><affiliation><nlm:aff id="aff001">Department of Clinical Medicine and Surgery,<institution>University “Federico II”</institution>,<addr-line>Naples</addr-line></nlm:aff></affiliation></author><author><name sortKey="Petrosillo, Nicola" sort="Petrosillo, Nicola" uniqKey="Petrosillo N" first="Nicola" last="Petrosillo">Nicola Petrosillo</name><affiliation><nlm:aff id="aff002"><institution>National Institute for Infectious Diseases “L. Spallanzani”</institution>,<addr-line>IRCCS, Rome, Italy</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32201554</idno><idno type="pmc">7073717</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073717</idno><idno type="RBID">PMC:7073717</idno><idno type="doi">10.4081/idr.2020.8516</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000883</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000883</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">COVID-19 R0: Magic number or conundrum?</title><author><name sortKey="Viceconte, Giulio" sort="Viceconte, Giulio" uniqKey="Viceconte G" first="Giulio" last="Viceconte">Giulio Viceconte</name><affiliation><nlm:aff id="aff001">Department of Clinical Medicine and Surgery,<institution>University “Federico II”</institution>,<addr-line>Naples</addr-line></nlm:aff></affiliation></author><author><name sortKey="Petrosillo, Nicola" sort="Petrosillo, Nicola" uniqKey="Petrosillo N" first="Nicola" last="Petrosillo">Nicola Petrosillo</name><affiliation><nlm:aff id="aff002"><institution>National Institute for Infectious Diseases “L. Spallanzani”</institution>,<addr-line>IRCCS, Rome, Italy</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">Infectious Disease Reports</title><idno type="ISSN">2036-7430</idno><idno type="eISSN">2036-7449</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Azhar, Ei" uniqKey="Azhar E">EI Azhar</name></author><author><name sortKey="Hui, Dsc" uniqKey="Hui D">DSC Hui</name></author><author><name sortKey="Memish, Za" uniqKey="Memish Z">ZA Memish</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hui, Dsc" uniqKey="Hui D">DSC Hui</name></author><author><name sortKey="Zumla, A" uniqKey="Zumla A">A. Zumla</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, N" uniqKey="Chen N">N Chen</name></author><author><name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name></author><author><name sortKey="Dong, X" uniqKey="Dong X">X Dong</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, D" uniqKey="Wang D">D Wang</name></author><author><name sortKey="Hu, B" uniqKey="Hu B">B Hu</name></author><author><name sortKey="Hu, C" uniqKey="Hu C">C Hu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Delamater, Pl" uniqKey="Delamater P">PL Delamater</name></author><author><name sortKey="Street, Ej" uniqKey="Street E">EJ Street</name></author><author><name sortKey="Leslie, Tf" uniqKey="Leslie T">TF Leslie</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Y" uniqKey="Liu Y">Y Liu</name></author><author><name sortKey="Gayle, Aa" uniqKey="Gayle A">AA Gayle</name></author><author><name sortKey="Wilder Smith, A" uniqKey="Wilder Smith A">A Wilder-Smith</name></author><author><name sortKey="Rocklov, J" uniqKey="Rocklov J">J. Rocklöv</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bauch, Ct" uniqKey="Bauch C">CT Bauch</name></author><author><name sortKey="Lloyd Smith, Jo" uniqKey="Lloyd Smith J">JO Lloyd-Smith</name></author><author><name sortKey="Coffee, Mp" uniqKey="Coffee M">MP Coffee</name></author><author><name sortKey="Galvani, Ap" uniqKey="Galvani A">AP Galvani</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Al Tawfiq, Ja" uniqKey="Al Tawfiq J">JA Al-Tawfiq</name></author><author><name sortKey="Memish, Za" uniqKey="Memish Z">ZA Memish</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Riley, S" uniqKey="Riley S">S Riley</name></author><author><name sortKey="Fraser, C" uniqKey="Fraser C">C Fraser</name></author><author><name sortKey="Donnelly, Ca" uniqKey="Donnelly C">CA Donnelly</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gumel, Ab" uniqKey="Gumel A">AB Gumel</name></author><author><name sortKey="Ruan, S" uniqKey="Ruan S">S Ruan</name></author><author><name sortKey="Day, T" uniqKey="Day T">T Day</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hellewell, J" uniqKey="Hellewell J">J Hellewell</name></author><author><name sortKey="Abbott, S" uniqKey="Abbott S">S Abbott</name></author><author><name sortKey="Gimma, A" uniqKey="Gimma A">A Gimma</name></author></analytic></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Rep</journal-id><journal-id journal-id-type="publisher-id">IDR</journal-id><journal-title-group><journal-title>Infectious Disease Reports</journal-title></journal-title-group><issn pub-type="ppub">2036-7430</issn><issn pub-type="epub">2036-7449</issn><publisher><publisher-name>PAGEPress Publications, Pavia, Italy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32201554</article-id><article-id pub-id-type="pmc">7073717</article-id><article-id pub-id-type="doi">10.4081/idr.2020.8516</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>COVID-19 R0: Magic number or conundrum?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Viceconte</surname><given-names>Giulio</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Petrosillo</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff001"><label>1</label>Department of Clinical Medicine and Surgery,<institution>University “Federico II”</institution>,<addr-line>Naples</addr-line></aff><aff id="aff002"><label>2</label><institution>National Institute for Infectious Diseases “L. Spallanzani”</institution>,<addr-line>IRCCS, Rome, Italy</addr-line></aff><author-notes><corresp id="cor1">National Institute for Infectious Diseases “L. Spallanzani”, IRCCS, Via Portuense 292, 00149 Rome, Italy. <phone>+39.0655170432</phone> - <fax>+39.0655170486</fax>. <email>nicola.petrosillo@inmi.it</email></corresp><fn fn-type="COI-statement"><p>Conflict of interest: None.</p></fn></author-notes><pub-date pub-type="epub"><day>24</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><day>25</day><month>2</month><year>2020</year></pub-date><volume>12</volume><issue>1</issue><elocation-id>8516</elocation-id><history><date date-type="received"><day>21</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>©Copyright: the Author(s), 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Licensee PAGEPress, Italy</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</uri>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><kwd-group><title>Key words</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>reproductive number</kwd><kwd>transmission</kwd></kwd-group><counts><fig-count count="0"></fig-count><table-count count="0"></table-count><equation-count count="0"></equation-count><ref-count count="15"></ref-count><page-count count="2"></page-count></counts></article-meta></front><body><p>There is an increasing concern about COVID-19 worldwide. This is a new emerging infectious disease caused by a novel coronavirus (SARS-CoV-2), which recently broke out from the Chinese city of Wuhan and has quickly spread in China, with sporadic cases in each continent.<sup><xref rid="ref1" ref-type="bibr">1</xref></sup></p><p>At the date of February 20th, 2020, SARS-CoV-2 caused 74 675 infections in China with 2 121 deaths, and 1 073 infections in 26 countries with 8 deaths outside China.<sup><xref rid="ref1" ref-type="bibr">1</xref></sup></p><p>COVID-19 represents the third coronavirus- associated epidemic to emerge from a species leap from wild animals to humans, after Severe Acute Respiratory Syndrome (SARS) in 2003, and the Middle East Respiratory Syndrome (MERS) in 2012.<sup><xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref></sup> SARS-CoV-2 Often causes a respiratory disease, similar to SARS and MERS, ranging from mild upper respiratory illness to a severe interstitial pneumonia, also requiring intensive care.<sup><xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref5" ref-type="bibr">5</xref></sup></p><p>One of the most discussed issues about COVID-19 is its basic reproduction number (R0). Public opinion and mass media are increasingly focusing on this epidemiological value, often alarming about the spreading potential of this novel infection, defining R0 as a “fatal number”: the more it increases, the greater is the risk for the population, including higher mortality potential.</p><p>On the other hand, the scientific community has not given a definite and sound response about the real epidemiological potential of COVID-19, to date. Scientists are currently debating about the actual reproductive number of COVID-19 and it is not hard to find sensationalistic statements about the R0 and its impact on the pandemic COVID-19 potential. Indeed, since COVID-19 broke out, several published study aiming to forecast its epidemic trend, have estimated different R0 values, often much higher than that of SARS and MERS.</p><p>R0 is the average number of secondary infections produced by an infectious case in a population where everyone is susceptible and it is used to measure the transmission potential of a communicable disease.<sup><xref rid="ref6" ref-type="bibr">6</xref></sup></p><p>When R0 is >1, it means that each individual affected by a transmittable disease is expected to infect a number of subjects that increase exponentially with the increase of the R0 value and the disease is expected to spread through the susceptible population. Conversely, when R0 is <1 each case transmits the disease to one or less than one individual and the disease is expected to die out in the population.<sup><xref rid="ref6" ref-type="bibr">6</xref></sup></p><p>Although the concept of R0 is very intuitive, its calculation is based on complex models and may lead to misinterpretations, especially for what concerns the real weight that R0 has on the spreading of an infectious disease and on the feasibility of controlling an epidemic.<sup><xref rid="ref6" ref-type="bibr">6</xref></sup></p><p>The basic reproductive number (R0) of COVID-19 has been initially estimated by the World Health Organization (WHO) to range between 1.4 and 2.5, as declared in the statement regarding the outbreak of SARS-CoV-2, dated 23th January 2020.<sup><xref rid="ref7" ref-type="bibr">7</xref></sup></p><p>However, several published studies aimed to precisely estimate the COVID-19 R0. A recent review written by Liu <italic>et al.</italic> compared 12 studies published from the 1st of January to the 7th of February 2020 which have estimated the R0 for COVID- 19, finding a range of values between 1.5 and 6.68.<sup><xref rid="ref8" ref-type="bibr">8</xref></sup> The authors of the review calculated the mean and the median of R0 estimated by the 12 studies and they found a final mean and median value of R0 for COVID-19 of 3.28 and 2.79, respectively, with an interquartile range (IQR) of 1.16.<sup><xref rid="ref8" ref-type="bibr">8</xref></sup> According to these findings, the COVID-19 R0 would exceed the reproductive number estimated for SARS.<sup><xref rid="ref9" ref-type="bibr">9</xref></sup></p><p>The reasons behind a low level of accordance between studies attempting to estimate the R0 are complex and can be attributed to 3 possible reasons: i) different variables considered; ii) different methods for modeling; and iii) different estimation procedures.<sup><xref rid="ref9" ref-type="bibr">9</xref></sup></p><p>Firstly, R0 is not an intrinsic variable of the infectious agent, but it is calculated through at least three parameters: the duration of contagiousness; the likelihood of infection per contact between; and the contact rate, along with economical, social and environmental factors, that may vary among studies aimed to estimate the R0.</p><p>More, the use of different models for the estimation of R0 may play a role in the discrepancies observed among the studies on COVID-19. In fact, according to Liu’s findings, the studies using mathematical methods produce estimates that are higher than stochastic and statistic models in determining COVID-19 R0.<sup><xref rid="ref8" ref-type="bibr">8</xref></sup></p><p>It must be noted that the estimation of R0 assumes that the number of secondary infections produced by a single case has no variations.<sup><xref rid="ref9" ref-type="bibr">9</xref></sup> However, super-spreading events, in which a single individual, not necessarily strongly symptomatic, may infect a wide number of subjects, as occurred in the past with SARS and MERS, may occur.<sup><xref rid="ref10" ref-type="bibr">10</xref></sup> Recently, a British businessman with COVID-19 has been alleged to transmit the infection to 11 people in a French chalet.<sup><xref rid="ref11" ref-type="bibr">11</xref></sup></p><p>Therefore, the models used to estimate the R0 cannot fully consider the large heterogeneity in space, transmissibility, and susceptibility of an infection.</p><p>Additionally, the basic reproductive number is constantly modified during an epidemic by the control measures adopted to reduce the fundamental coefficient of R0, namely: i) the duration of contagiousness; ii) the likelihood of infection per contact; and iii) the contact rate.<sup><xref rid="ref12" ref-type="bibr">12</xref></sup></p><p>One effective measure is quarantine. During SARS epidemic, several countries introduced the use of mass quarantine for all individuals suspected of having had contact with a confirmed SARS case. These coordinated global efforts were remarkably effective at curtailing the spread of the disease, and this strategy was effective, together with isolation of infected patients and public health measures to contain the epidemic and avoiding SARS reemergence.</p><p>Another important value that has not received sufficient attention to date is the control reproductive number (Rc) that is the value of R in the presence of control measures. If Rc can be sustained at values below one, then the disease will eventually be eradicated.<sup><xref rid="ref13" ref-type="bibr">13</xref></sup> It must be noted that the forecast of an epidemic trend and of our ability to control it, cannot rely only on R0, but must also take into account several variables, <italic>i.e</italic>.: i) the number of initial cases; ii) the delay from symptom onset to isolation; iii) the probability contacts are traced; iv) the proportion of transmission that occurred before symptom onset, v) and the proportion of subclinical infections.<sup><xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref14" ref-type="bibr">14</xref></sup></p><p>Basing on stochastic variation of the above-mentioned variables, Hellewell and colleagues recently forecasted the potential effectiveness of contact tracing and isolation of COVID-19 cases, using different values of R0.<sup><xref rid="ref14" ref-type="bibr">14</xref></sup> According to their findings, with an R0 of 1.5, COVID-19 outbreaks would be contained if less than 50% of contacts will be successfully traced. For R0 of 2.5 and 3.5, more than 70% and 90% of contacts respectively have to be traced. However, according to Helleweel <italic>et al</italic>., the probability of control decreases with longer delays from symptom onset to isolation, fewer cases ascertained by contact tracing, and increasing transmission before symptoms. <sup><xref rid="ref14" ref-type="bibr">14</xref></sup></p><p>Notably, according to a recent large descriptive study carried out by the Chinese Center for Disease Control and Prevention (CCDC) on 72,314 individuals diagnosed with COVID-19 in China, 81% of the cases had mild symptoms and 1.2% were asymptomatic. <sup><xref rid="ref15" ref-type="bibr">15</xref></sup> These cases may contribute to the spreading of the disease despite adequate control measures. Nonetheless, a decreasing trend of infections emerges by the analysis of the epidemic curves provided by the authors, which may indicate the effectiveness of the control measure adopted to date.<sup><xref rid="ref15" ref-type="bibr">15</xref></sup></p><p>In conclusion, the basic reproductive number of COVID-19, although is a precious variable to forecast the spreading potential of an infectious disease, is not the only factor to consider when estimating the burden of the epidemic. There is much more to known about this new infection: what is the transmission ability of asymptomatic carriers? What is the proportion of infected cases missed at the tracing and control procedures? Are the current strategies to prevent the spreading of the infection effective? Global efforts are, therefore, needed to address all these questions.</p></body><back><ack><title>Acknowledgments</title><p>This work is supported by Ricerca Corrente, IRCCS, Italian Ministry of Health.</p></ack><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <article-title>Coronavirus disease 2019 (COVID-19) Situation Report-31, 20th February</article-title><year>2020</year> Available from: <comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200220-sitrep-31-covid-19.pdf?sfvrsn=dfd11d24_2">https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200220-sitrep-31-covid-19.pdf?sfvrsn=dfd11d24_2</ext-link></comment>.</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azhar</surname><given-names>EI</given-names></name><name><surname>Hui</surname><given-names>DSC</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name><etal></etal></person-group><article-title>The Middle East Respiratory Syndrome (MERS)</article-title>. <source>Infect Dis Clin North Am</source><year>2019</year>;<volume>33</volume>:<fpage>891</fpage>–<lpage>905</lpage>.<pub-id pub-id-type="pmid">31668197</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DSC</given-names></name><name><surname>Zumla</surname><given-names>A.</given-names></name></person-group><article-title>Severe Acute Respiratory Syndrome</article-title>. <source>Infect Dis Clin North Am</source><year>2019</year>;<volume>3</volume>:<fpage>869</fpage>-<lpage>89</lpage>.</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><etal></etal></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title>. <source>Lancet</source><year>2020</year> Jan 30</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus- Infected Pneumonia in Wuhan, China</article-title>. <source>JAMA</source><year>2020</year> Feb 7.</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delamater</surname><given-names>PL</given-names></name><name><surname>Street</surname><given-names>EJ</given-names></name><name><surname>Leslie</surname><given-names>TF</given-names></name><etal></etal></person-group><article-title>Complexity of the Basic Reproduction Number (R0)</article-title>. <source>Emerg Infect Dis</source><year>2019</year>;<volume>25</volume>:<fpage>1</fpage>-<lpage>4</lpage>.</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><collab>Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus 2019 (n- CoV) on 23 January</collab><year>2020</year> Available from: <comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/23-01-2020-statement-on-themeeting-of-the-international-healthregulations-(2005)-emergency-committee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov)">https://www.who.int/news-room/detail/23-01-2020-statement-on-themeeting-of-the-international-healthregulations-(2005)-emergency-committee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov)</ext-link></comment></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gayle</surname><given-names>AA</given-names></name><name><surname>Wilder-Smith</surname><given-names>A</given-names></name><name><surname>Rocklöv</surname><given-names>J.</given-names></name></person-group><article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title>. <source>J Travel Med</source><year>2020</year> Feb 13</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauch</surname><given-names>CT</given-names></name><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Coffee</surname><given-names>MP</given-names></name><name><surname>Galvani</surname><given-names>AP</given-names></name></person-group><article-title>Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses</article-title>. <source>Epidemiology</source><year>2005</year>;<volume>16</volume>:<fpage>791</fpage>-<lpage>801</lpage>.<pub-id pub-id-type="pmid">16222170</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Drivers of MERS-CoV transmission: what do we know?</article-title><source>Exp Rev Respir Med</source><year>2016</year>;<volume>10</volume>: <fpage>331</fpage>-<lpage>8</lpage>.</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <article-title>Coronavirus disease 2019 (COVID-19) Situation Report-24, 13th February</article-title><year>2020</year> Available from: <comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200213-sitrep-24-covid-19.pdf?sfvrsn=9a7406a4_4">https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200213-sitrep-24-covid-19.pdf?sfvrsn=9a7406a4_4</ext-link></comment>.</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><etal></etal></person-group><article-title>Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions</article-title>. <source>Science</source><year>2003</year>;<volume>300</volume>:<fpage>1961</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">12766206</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumel</surname><given-names>AB</given-names></name><name><surname>Ruan</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Modelling strategies for controlling SARS outbreaks</article-title>. <source>Proc R Soc B Biol Sci</source><year>2004</year>;<volume>271</volume>:<fpage>2223</fpage>-<lpage>32</lpage>.</mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Gimma</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Feasibility of controlling 2019-nCoV outbreaks by isolation of cases and contacts</article-title>. <source>med Rxiv</source><year>2020</year> Feb 11; 2020.02.08.20021162.</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><collab>The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China</collab>, <year>2020</year> [cited 2020 Feb 20]. Available from: <comment><ext-link ext-link-type="uri" xlink:href="http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51">http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51</ext-link></comment></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:7073717
|texte= COVID-19 R0: Magic number or conundrum?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:32201554" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |